Global Cardiac Rhythm Management Devices Market Report Size, Trends & Growth Opportunity, By Product, By Region and forecast till 2027
Report ID : QR1001332 | Industries : Healthcare | Published On :January 2022 | Page Count : 239Global Cardiac Rhythm Management Devices Market
The devices used for capturing irregular heartbeats and identify rhythm disorder and to determine the right course of treatment are the Cardiac monitors. They monitor the nonstop and intermittent heart activity via electrocardiography. Cardiac Rhythm Management devices are used to assist in the diagnosis of health conditions like unexplained stroke, unexplained fainting, atrial fibrillation, heart palpitations, and others. While cardiac rhythm management devices are used when the heart does not function efficiently.
Market Drivers
Growing incidence of cardiovascular diseases at an early stage, rise in the geriatric population, increasing obese population is the factors that are projected to boost the growth of global cardiac monitoring and cardiac rhythm management devices market.
Growing investment for the development of advanced technological devices, changing lifestyle of the people, growing usages of home care and ambulatory services for cardiac monitoring are some of the factors that will boost the growth of the cardiac rhythm management devices market in the forecast period.
Know more about this report: request for sample pages
Market Restraints
Rigorous government regulations, high cost incurred for the diagnosis and treatment of cardiovascular diseases, and the shortage of skilled professionals with expertise in electrocardiography and cardiac monitoring are few significant factors that are restricting the market growth. Also after effects of therapeutic radiation will likely to hamper the growth of the cardiac rhythm management devices market.
Regional Analysis
North America leads the cardiac rhythm management devices market because of the adoption of advanced technology along with growing number of geriatric population and prevalence of improved healthcare infrastructure.
Asia-Pacific is another region with high potential for this market, because of the increasing healthcare expenditure by the government, the growing the prevalence of cardiac disorders, and the rising per capita income of the population in the South Asian countries.
Market Key Players
Some of the key players operating in Global Cardiac Rhythm Management Devices Market are BIOTRONIK, ZOLL Medical, Boston Scientific, SCHILLER, Koninklijke Philips N.V., ABIOMED, Medtronic, Abbott.
Industry development
In January 2019, Medtronic acquired EPIX Therapeutics, which was aimed at expanding the former company’s cardiac ablation portfolio to treat patients with cardiac arrhythmias. CRM device makers are also introducing new technologies to enhance product performance and augment their portfolio.
In January 2019, Schiller introduced Epicardio Simulation, offering a new way to interact with a virtual heart.
Global Cardiac Rhythm Management Devices Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data End-users
3 Executive Summary
4 Cardiac Rhythm Management Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Cardiac Rhythm Management Devices Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Cardiac Rhythm Management Devices Market Share Analysis, By Product
5.3 Cardiac Rhythm Management Devices Market Size and Forecast, By Product
5.3.1 Defibrillators
5.3.1.1 Implantable Cardioverter Defibrillators (ICD)
5.3.1.2 External Defibrillator
5.3.2 Pacemakers
5.3.2.1 Implantable
5.3.2.2 External
5.3.3 Cardiac Resynchronization Therapy Devices
5.3.3.1 CRT-Defibrillator
5.3.3.2 CRT-Pacemakers
6 Cardiac Rhythm Management Devices Market, By Region
6.1 Cardiac Rhythm Management Devices Market Share Analysis, By Region
6.2 Cardiac Rhythm Management Devices Market Share Analysis, By Region
6.3 Cardiac Rhythm Management Devices Market Size and Forecast, By Region
7 North America Cardiac Rhythm Management Devices Market Analysis and Forecast (2021-2027)
7.1 Introduction
7.2 North America Cardiac Rhythm Management Devices Market Share Analysis, By Product
7.3 North America Cardiac Rhythm Management Devices Market Size and Forecast, By Country
7.3.1 U.S.
7.3.2 Canada
7.3.3 Mexico
8 Europe Cardiac Rhythm Management Devices Market Analysis and Forecast (2021-2027)
8.1 Introduction
8.2 Europe Cardiac Rhythm Management Devices Market Share Analysis, By Product
8.3 Europe Cardiac Rhythm Management Devices Market Size and Forecast, By Country
8.3.1 Germany
8.3.2 France
8.3.3 UK
8.3.3 Rest of Europe
9 Asia Pacific Cardiac Rhythm Management Devices Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 Asia Pacific Cardiac Rhythm Management Devices Market Share Analysis, By Product
9.3 Asia Pacific Cardiac Rhythm Management Devices Market Size and Forecast, By Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.3. Rest of Asia Pacific
10 Latin America Cardiac Rhythm Management Devices Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Latin America Cardiac Rhythm Management Devices Market Share Analysis, By Product
10.3 Latin America Cardiac Rhythm Management Devices Market Size and Forecast, Country
10.3.1. Brazil
10.3.2. Rest of Latin America
11 Middle East Cardiac Rhythm Management Devices Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Middle East Cardiac Rhythm Management Devices Market Share Analysis, By Product
11.3 Middle East Cardiac Rhythm Management Devices Market Size and Forecast, By Country
11.3.1. Saudi Arabia
11.3.2. UAE
11.3.3. Egypt
11.3.3. Kuwait
11.3.5. South Africa
12 Competitive Analysis
12.1 Competition Dashboard
12.2 Market share Analysis of Top Vendors
12.3 Key Development Strategies
13 Company Profiles
13.1 BIOTRONIK
13.1.1 Overview
13.1.2 Offerings
13.1.3 Key Financials
13.1.3 Business Segment & Geographic Overview
13.1.5 Key Market Developments
13.1.7 Key Strategies
13.2 ZOLL Medical
13.2.1 Overview
13.2.2 Offerings
13.2.3 Key Financials
13.2.3 Business Segment & Geographic Overview
13.2.5 Key Market Developments
13.2.7 Key Strategies
13.3 Boston Scientific
13.3.1 Overview
13.3.2 Offerings
13.3.3 Key Financials
13.3.3 Business Segment & Geographic Overview
13.3.5 Key Market Developments
13.3.7 Key Strategies
13.3 SCHILLER
13.3.1 Overview
13.3.2 Offerings
13.3.3 Key Financials
13.3.3 Business Segment & Geographic Overview
13.3.5 Key Market Developments
13.3.7 Key Strategies
13.5 Koninklijke Philips N.V.
13.5.1 Overview
13.5.2 Offerings
13.5.3 Key Financials
13.5.3 Business Segment & Geographic Overview
13.5.5 Key Market Developments
13.5.7 Key Strategies
13.6 ABIOMED
13.6.1 Overview
13.6.2 Offerings
13.6.3 Key Financials
13.6.3 Business Segment & Geographic Overview
13.6.5 Key Market Developments
13.6.6 Key Strategies
13.7 Medtronic
13.7.1 Overview
13.7.2 Offerings
13.7.3 Key Financials
13.7.3 Business Segment & Geographic Overview
13.7.5 Key Market Developments
13.7.6 Key Strategies
13.7 Abbott
13.7.1 Overview
13.7.2 Offerings
13.7.3 Key Financials
13.7.3 Business Segment & Geographic Overview
13.7.5 Key Market Developments
13.7.6 Key Strategies